ISSN 1004-4140
CN 11-3017/P

基于CT的细胞外容积分数评价透明细胞肾细胞癌WHO/ISUP病理分级

Evaluation of WHO/ISUP Pathological Grading of Clear Cell Renal Cell Carcinoma by CT-based Extracellular Volume Fraction

  • 摘要: 目的:探讨基于CT的细胞外容积分数(ECV)术前评价透明细胞肾细胞癌(ccRCC)WHO/ISUP病理分级的价值。方法:回顾性收集我院收治经手术后病理组织学证实的67例ccRCC患者,患者术前均行腹部CT平扫+三期增强扫描,根据WHO/ISUP分级,将Ⅰ、Ⅱ级纳为低级别组(48例),Ⅲ、Ⅳ级纳为高级别组(19 例)。采集两组患者的一般临床资料,测量计算定量参数,包括延迟期主动脉净增值(∆HUAorta)、延迟期肿瘤净增值(∆HUtumor)及ECV,并进行对比分析,通过绘制ROC曲线评价ECV 对ccRCC病理分级的诊断效能。结果:低级别组ccRCC的∆HUtumor及ECV均高于高级别组。ROC曲线显示,ECV评价WHO/ISUP低级别ccRCC的效能(AUC:0.834)高于∆HUtumor(AUC:0.725)。结论:基于CT的ECV术前评价ccRCC的病理分级具有一定的价值。

     

    Abstract: Objective: To investigate the value of computed tomography-based extracellular volume fraction (ECV) for preoperative evaluation of WHO/ISUP pathologic grading of clear cell renal cell carcinoma (ccRCC). Methods: Seventy-two patients with ccRCC who underwent postoperative histological confirmation were retrospectively enrolled. All patients underwent preoperative CT scanning of the abdomen and three-phase enhancement scanning according to the WHO/ISUP grading. Grades I and II were categorized as the low-grade group (48 patients) and grades III and IV were categorized as the high-grade group (19 patients). General clinical data of the two groups were collected, and quantitative parameters, including delayed aortic net value added (∆HUAorta ), delayed tumor net value added (∆HUtumor)and ECV, were measured and compared, and the diagnostic efficacy of ECV in the pathological grading of ccRCC was evaluated by plotting the ROC curve. Results: The ∆HUtumor and ECV of ccRCC in low-grade group were significantly higher than those in high-grade group (P<0.05). The ROC curves demonstrated that the efficiency of ECV in evaluating WHO/ISUP low-grade ccRCC (AUC: 0.834) was higher than that of ∆HUtumor(AUC:0.725). Conclusion: CT-based ECV is valuable for the preoperative evaluation of ccRCC pathological grade.

     

/

返回文章
返回